Polar Asset Management Partners Inc. Purchases New Position in Delcath Systems, Inc. (NASDAQ:DCTH)

Polar Asset Management Partners Inc. purchased a new stake in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 176,500 shares of the company's stock, valued at approximately $1,594,000. Polar Asset Management Partners Inc. owned 0.55% of Delcath Systems as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Shellback Capital LP acquired a new position in shares of Delcath Systems during the 2nd quarter worth approximately $1,353,000. Vanguard Group Inc. increased its stake in Delcath Systems by 31.0% during the 1st quarter. Vanguard Group Inc. now owns 683,686 shares of the company's stock worth $3,261,000 after acquiring an additional 161,678 shares during the period. Legato Capital Management LLC acquired a new position in Delcath Systems in the 2nd quarter valued at $966,000. Principal Financial Group Inc. bought a new stake in shares of Delcath Systems during the 3rd quarter valued at $808,000. Finally, Renaissance Technologies LLC acquired a new stake in shares of Delcath Systems during the 2nd quarter worth $694,000. Institutional investors own 61.12% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on DCTH shares. HC Wainwright reaffirmed a "buy" rating and issued a $22.00 price target on shares of Delcath Systems in a research note on Monday, November 11th. Canaccord Genuity Group reiterated a "buy" rating and issued a $21.00 target price on shares of Delcath Systems in a research report on Friday, October 18th. Stephens reiterated a "buy" rating on shares of Delcath Systems in a report on Friday, October 18th. Finally, StockNews.com upgraded shares of Delcath Systems from a "sell" rating to a "hold" rating in a research report on Friday, October 25th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $21.50.

Delcath Systems Price Performance

Shares of NASDAQ:DCTH traded up $0.39 during mid-day trading on Friday, hitting $11.87. The company had a trading volume of 239,726 shares, compared to its average volume of 283,613. The company has a market capitalization of $379.53 million, a PE ratio of -8.70 and a beta of 0.85. The firm has a fifty day moving average price of $10.11 and a 200 day moving average price of $8.94. Delcath Systems, Inc. has a one year low of $2.80 and a one year high of $12.88.

Delcath Systems Company Profile

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.